NUVB Nuvation Bio Inc.
Healthcare$4.65+0.00%OpenMarket Cap: $1.61B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.13
P/S
11.46
EV/EBITDA
-11.00
DCF Value
$3.38
FCF Yield
-7.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.6%
Operating Margin
-105.0%
Net Margin
-102.1%
ROE
-44.1%
ROA
-23.9%
ROIC
-27.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $83.2M | 93.3% | $3.9M | $5.4M | $— | — |
| Q4 null | $41.9M | 99.0% | $-34.0M | $-36.6M | $— | — |
| FY null | $62.9M | 86.6% | $-213.1M | $-204.6M | $— | — |
| Q3 null | $13.1M | 74.5% | $-56.4M | $-55.8M | $— | — |
| Q2 null | $4.8M | 46.7% | $-63.6M | $-59.0M | $— | — |
| Q1 null | $3.1M | 32.1% | $-59.0M | $-53.2M | $— | — |
| Q4 null | $5.7M | 26.2% | $-53.9M | $-49.4M | $— | — |
| FY null | $7.9M | 10.1% | $-592.6M | $-567.9M | $— | — |
| Q3 null | $727.0K | -108.4% | $-48.1M | $-41.2M | $— | — |
| Q2 null | $1.4M | 6.1% | $-470.4M | $-462.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-20.2M | $-14.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-20.8M | $-13.8M | $-0.06 | — |